Multiple Myeloma Research Foundation spearheads genome sequencing

Wed, 03/23/2011 - 10:33am
Mass High Tech: The Journal of New England Technology

Researchers at the Broad Institute in Cambridge and their collaborators, funded by the Multiple Myeloma Research Foundation, have sequenced the first multiple myeloma genome, a discovery they said could help drug developers better understand the disease and create new targets to treat it.

“The significance of the study is this is the first time the entire genome in multiple myeloma has been sequenced,” Kenneth Anderson, chief of the division of hematologic neoplasia at Boston’s Dana-Farber Cancer Institute, told Mass High Tech. “These studies allow us to better understand the genes that cause or are important in multiple myeloma. The clinical significance is to better segment patients and identify targets for potential novel treatments.” The research was published in this week’s issue of Nature magazine.



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.